Synthesis and biological evaluation of novel hydrogen sulfide releasing glycyrrhetic acid derivatives

References

• Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?. FASEB J 2002;16:1792–8
   PubMed Web of Science ®Google Scholar
• Caliendo G, Cirino G, Santagada V, Wallace JL. Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals. J Med Chem 2010;53:6275–86
   PubMed Web of Science ®Google Scholar
• Distrutti E, Sediari L, Mencarelli A, et al. Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. J Pharmacol Exp Ther 2006;316:325–35
   PubMed Web of Science ®Google Scholar
• Jia J, Xiao Y, Wang W, et al. Differential mechanisms underlying neuroprotection of hydrogen sulfide donors against oxidative stress. Neurochem Int 2013;62:1072–8
   PubMed Web of Science ®Google Scholar
• Wang Y, Jia J, Ao GZ, et al. Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia. J Neurochem 2014;129:827–38
   PubMed Web of Science ®Google Scholar
• Zhou X, Cao Y, Ao GZ, et al. CaMKKβ-dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation. Antioxid Redox Signal 2014;21:1741–58
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Orlandi S, Mencarelli A, et al. Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol 2007;150:996–1002
   PubMed Web of Science ®Google Scholar
• Wallace JL. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol Sci 2007;28:501–6
   PubMed Web of Science ®Google Scholar
• Wallace JL, Caliendo G, Santagada V, Cirino G. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). Brit J Pharmacol 2010;159:1236–46
   PubMed Web of Science ®Google Scholar
• Chattopadhyay M, Kodela R, Nath N, et al. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo. Biochem Pharmacol 2012;83:723–32
   PubMed Web of Science ®Google Scholar
• Chattopadhyay M, Kodela R, Nath N, et al. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect. Biochem Pharmacol 2012;83:715–22
   PubMed Web of Science ®Google Scholar
• Chattopadhyay M, Kodela R, Nath N, et al. Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo. Biochem Pharmacol 2012;83:733–40
   PubMed Web of Science ®Google Scholar
• Kodela R, Chattopadhyay M, Kashfi K. NOSH-aspirin: a novel nitric oxide-hydrogen sulfide-releasing hybrid: a new class of anti-inflammatory pharmaceuticals. ACS Med Chem Lett 2012;3:257–62
   PubMed Web of Science ®Google Scholar
• Wang CY, Kao TC, Lo WH, Yen GC. Glycyrrhizic acid and 18β-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-κB through PI3K p110δ and p110γ inhibitions. J Agric Food Chem 2011;59:7726–33
   PubMed Web of Science ®Google Scholar
• Kao TC, Shyu MH, Yen GC. Glycyrrhizic acid and 18beta-glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3beta signaling and glucocorticoid receptor activation. J Agric Food Chem Food 2010;58:8623–9
   PubMed Web of Science ®Google Scholar
• Takahashi K, Shibata S, Yano S, et al. Chemical modification of glycyrrhetinic acid in relation to the biological activities. Chem Pharm Bull 1980;28:3449–52
   PubMed Web of Science ®Google Scholar
• Beseda I, Czollner L, Shah PS, et al. Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases. Bioorg Med Chem 2010;18:433–54
   PubMed Web of Science ®Google Scholar
• Kalani K, Kushwaha V, Verma R, et al. Glycyrrhetinic acid and its analogs: a new class of antifilarial agents. Bioorg Med Chem Lett 2013;23:2566–70
   PubMed Web of Science ®Google Scholar
• Song J, Ko Hs, Sohn EJ, et al. Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells. Bioorg Med Chem Lett 2014;24:1188–91
   PubMed Web of Science ®Google Scholar
• Carraher CE Jr., Ngoc Trang Caroline T, Roner MR, et al. Synthesis of organotin poly(ether esters) from reaction with glycyrrhetinic acid and their preliminary activity against various cancer cell lines. Inorg Chim Acta 2014;423:83–92
   Web of Science ®Google Scholar
• Jiang L, Wang Q, Shen S, et al. Discovery of glycyrrhetinic acid as an orally active, direct inhibitor of blood coagulation factor xa. Thromb Res 2014;133:501–6
   PubMed Web of Science ®Google Scholar
• Jayasooriya RGPT, Dilshara MG, Park SR, et al. 18β-Glycyrrhetinic acid suppresses TNF-α induced matrix metalloproteinase-9 and vascular endothelial growth factor by suppressing the Akt-dependent NF-κB pathway. Toxicol In Vitro 2014;28:751–8
   PubMed Web of Science ®Google Scholar
• Schwarz S, Siewert B, Xavier NM, et al. A “natural” approach: synthesis and cytoxicity of monodesmosidic glycyrrhetinic acid glycosides. Eur J Med Chem 2014;72:78–83
   PubMed Web of Science ®Google Scholar
• Fu XX, Du LL, Zhao N, et al. 18β-Glycyrrhetinic acid potently inhibits Kv1.3 potassium channels and T cell activation in human Jurkat T cells. J Ethnopharmacol 2013;148:647–54
   PubMed Web of Science ®Google Scholar
• Salomatina OV, Markov AV, Logashenko EB, et al. Synthesis of novel 2-cyano substituted glycyrrhetinic acid derivatives as inhibitors of cancer cells growth and NO production in LPS-activated J-774 cells. Bioorg Med Chem 2014;22:585–93
   PubMed Web of Science ®Google Scholar
• Parida PK, Sau A, Ghosh T, et al. Synthesis and evaluation of triazole linked glycosylated 18β-glycyrrhetinic acid derivatives as anticancer agents. Bioorg Med Chem Lett 2014;24:3865–8
   PubMed Web of Science ®Google Scholar
• Gao C, Dai FJ, Cui HW, et al. Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity. Chem Biol Drug Des 2014;84:223–33
   PubMed Web of Science ®Google Scholar
• You R, Long W, Lai Z, et al. Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile. J Med Chem 2013;56:1984–95
   PubMed Web of Science ®Google Scholar
• Ao GZ, Qiao CH, Hou BB, et al. Glycyrrhetinic acid derivatives and their application as antitumor agents. Soochow University. CN102241726; 2013
   Google Scholar
• Ao GZ, Xu GL, Yang SW, et al. Application of glycyrrhetinic acid derivatives in the preparation of medicine for anti-inflammation. Soochow University. CN102579462; 2013
   Google Scholar
• Bennett F, Girijavallabhan VM, Patel NM, et al. Tetrahydrofuran phosphate- and hydroxy esters, as prodrugs for the corresponding antifungal agent. Assignee. Schering Corporation, WO. 9915522; 1999
   Google Scholar
• Gok Y, Alici B, Cetinkaya E, et al. Ionic liquids as solvent for efficient esterification of carboxylic acids with alkyl halides. Turk J Chem 2010;34:187–91
   Web of Science ®Google Scholar
• Csuk R, Schwarz S, Kluge R, Stroehl D. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid. Eur J Med Chem J Med. 2010;45:5718–23
   PubMed Web of Science ®Google Scholar
• Yong JP, Wang JW, Aisa HA, Liu L. Synthesis of glycyrrhetic acid derivatives. J Chem Nat Compd 2008;44:194–6
   Web of Science ®Google Scholar
• Xu GL, Du YF, Cheng J, et al. Inhibition of inflammatory mediators contributes to the anti-inflammatory activity of KYKZL-1 via MAPK and NF-κB pathway. Toxicol Appl Pharmacol 2013;272:221–9
   PubMed Web of Science ®Google Scholar
• Xu GL, Liu F, Ao GZ, et al. Anti-inflammatory effects and gastrointestinal safety of NNU-hdpa, a novel dual COX/5-LOX inhibitor. Eur J Pharmacol 2009;611:100–6
   PubMed Web of Science ®Google Scholar
• Huang B, Du D, Zhang R, et al. Synthesis, characterization and biological studies of diosgenyl analogues. Bioorg Med Chem Lett 2012;22:7330–4
   PubMed Web of Science ®Google Scholar
• Atherden LM. Studies with glycyrrhetic acid; inhibition of metabolism of steroids in vitro. Biochem J 1958;69:75–8
   PubMed Web of Science ®Google Scholar
• Xu YY, Cao Y, Ma H, et al. Design, synthesis and molecular docking of α,β-unsaturated cyclohexanone analogous of curcumin as potent EGFR inhibitors with antiproliferative activity. Bioorg Med Chem 2013;21:388–94
   PubMed Web of Science ®Google Scholar